2021 New Mexico Statutes
Article 31B - Drug Precursors
Section 30-31B-15 - Administrative inspections.

A. When authorized by an administrative inspection warrant issued pursuant to the Drug Precursor Act, a law enforcement officer or employee of the board, upon presenting the warrant and appropriate credentials to the owner, operator or agent in charge, may enter the controlled premises for the purpose of conducting an administrative inspection.
B. When authorized by an administrative inspection warrant, a law enforcement officer or employee of the board may:
(1) inspect and copy records required to be kept by the Drug Precursor Act;
(2) inspect and sample, within reasonable limits and in a reasonable manner, controlled premises and all pertinent equipment, finished and unfinished material, containers and labeling found therein, and, except as provided in Subsection D of this section, all other things bearing on violation of the Drug Precursor Act, including records, files, papers, processes, controls and facilities; and
(3) inventory any stock of any drug precursor and obtain samples.
C. This section does not prevent entries and administrative inspections, including seizures of property, without a warrant:
(1) if the owner, operator or agent in charge of the controlled premises consents;
(2) in situations presenting substantial imminent danger to health or safety; or
(3) in all other situations in which a warrant is not constitutionally required.
D. An inspection authorized by this section shall not extend to financial data, sales data other than shipment data or pricing data unless the owner, operator or agent in charge of the controlled premises consents in writing.
E. When perishable or dangerous substances or equipment are seized pursuant to Subsection C of this section, the law enforcement officer or employee of the board may apply to the district court for an order to sell or destroy said property and deposit the proceeds of any sale with the court.
F. For purposes of this section "controlled premises" means:
(1) places where persons licensed or exempted from license requirements under the Drug Precursor Act are required to keep records; and
(2) places, including factories, warehouses, establishments and conveyances in which persons licensed or exempted from license requirements under the Drug Precursor Act are permitted to hold, manufacture, compound, process, sell, deliver or otherwise dispose of any drug precursor.
History: Laws 1989, ch. 177, § 15.